The present results elucidate a potential mechanism underlying the tumor-oncogenic role of NEAT1 in NSCLC, and indicate that NEAT1 could be a useful marker and potential therapeutic target in NSCLC. The gene discussed is NEAT1; the disease is non-small cell lung carcinoma.